Trademark: 79351830
Word
SOLQIXRY
Status Date
Tuesday, March 19, 2024
Registration Number
7330144
Registration Date
Tuesday, March 19, 2024
Filing Date
Thursday, August 25, 2022
Published for Opposition
Tuesday, January 2, 2024
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Oct 21, 2022
Application Filing Receipt Mailed
Oct 6, 2022
Sn Assigned For Sect 66a Appl From Ib
Oct 14, 2022
Limitation From Original Application Entered
Oct 17, 2022
New Application Office Supplied Data Entered
Nov 3, 2022
Assigned To Examiner
Nov 7, 2022
Teas Change Of Owner Address Received
Nov 7, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 7, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 7, 2022
Teas Change Of Domestic Representatives Address
Nov 7, 2022
Teas Change Of Correspondence Received
Nov 7, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 7, 2022
Non-Final Action Written
Nov 8, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jan 18, 2023
Refusal Processed By Mpu
Jan 18, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Nov 21, 2023
Teas/Email Correspondence Entered
Feb 7, 2023
Refusal Processed By Ib
Jun 16, 2023
Teas Response To Office Action Received
Nov 20, 2023
Assigned To Lie
Nov 21, 2023
Correspondence Received In Law Office
Nov 27, 2023
Approved For Pub - Principal Register
Dec 13, 2023
Notification Of Notice Of Publication E-Mailed
Dec 13, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 13, 2023
Notification Of Possible Opposition Sent To Ib
Jan 2, 2024
Published For Opposition
Jan 2, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 6, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 19, 2024
Registered-Principal Register
Mar 19, 2024
Notice Of Registration Confirmation Emailed
Mar 26, 2024
Notification Of Possible Opposition - Processed By Ib
Jan 2, 2024
Notification Processed By Ib
Mar 6, 2024
Notification Of Possible Opposition Sent To Ib
Jun 20, 2024
Final Disposition Notice Created, To Be Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
